StockClub

JANX

JANXJanux Therapeutics, Inc.$ --
Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

JANX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
4M USD
YoY +Infinity%
Operating Income
-34M USD
YoY +2.0%
Net Income
-24M USD
YoY -3.6%
EPS
-0.39$
YoY -2.6%

Revenue

$3.7M
FY2024 Q2$10.1M
$10.1M
Q2
FY2024 Q3$10.6M
$10.6M
Q3
FY2024 Q4$10.6M
$10.6M
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$10M
$10M
Q3
FY2025 Q4$17.9M
$17.9M
Q4
FY2026 Q1$3.7M
$3.7M
Q1
Actual
+$3.7M (-)

Net Income

$-24.4M
FY2024 Q2$-20.7M
$-20.7M
Q2
FY2024 Q3$-48.8M
$-48.8M
Q3
FY2024 Q4$-69M
$-69M
Q4
FY2025 Q1$-23.5M
$-23.5M
Q1
FY2025 Q2$-57.4M
$-57.4M
Q2
FY2025 Q3$-81.7M
$-81.7M
Q3
FY2025 Q4$-113.6M
$-113.6M
Q4
FY2026 Q1$-24.4M
$-24.4M
Q1
Actual
$-853,000 (-3.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021BEAT
Actual:$3.6M
Est:$2.4M
FY2021BEAT
$3.6M
FY2022BEAT
Actual:$8.6M
Est:$6.6M
FY2022BEAT
$8.6M
FY2023MISS
Actual:$8.1M
Est:$15.1M
FY2023MISS
$8.1M
FY2024MISS
Actual:$10.6M
Est:$11M
FY2024MISS
$10.6M
FY2025MISS
Actual:$10M
Est:$10.1M
FY2025MISS
$10M

Analyst Estimates